[go: up one dir, main page]

DK1485818T3 - Generering af en behandlingsprotokol for sygdomme relateret til angiogenese - Google Patents

Generering af en behandlingsprotokol for sygdomme relateret til angiogenese

Info

Publication number
DK1485818T3
DK1485818T3 DK02801985T DK02801985T DK1485818T3 DK 1485818 T3 DK1485818 T3 DK 1485818T3 DK 02801985 T DK02801985 T DK 02801985T DK 02801985 T DK02801985 T DK 02801985T DK 1485818 T3 DK1485818 T3 DK 1485818T3
Authority
DK
Denmark
Prior art keywords
angiogenesis
treatment protocol
incorporated
pro
factors
Prior art date
Application number
DK02801985T
Other languages
Danish (da)
English (en)
Inventor
Zvia Agur
Levon Arakelyan
Vladimir Vainstein
Original Assignee
Optimata Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Optimata Ltd filed Critical Optimata Ltd
Application granted granted Critical
Publication of DK1485818T3 publication Critical patent/DK1485818T3/da

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01F—MEASURING VOLUME, VOLUME FLOW, MASS FLOW OR LIQUID LEVEL; METERING BY VOLUME
    • G01F1/00—Measuring the volume flow or mass flow of fluid or fluent solid material wherein the fluid passes through a meter in a continuous flow
    • G01F1/05—Measuring the volume flow or mass flow of fluid or fluent solid material wherein the fluid passes through a meter in a continuous flow by using mechanical effects
    • G01F1/20—Measuring the volume flow or mass flow of fluid or fluent solid material wherein the fluid passes through a meter in a continuous flow by using mechanical effects by detection of dynamic effects of the flow
    • G01F1/32—Measuring the volume flow or mass flow of fluid or fluent solid material wherein the fluid passes through a meter in a continuous flow by using mechanical effects by detection of dynamic effects of the flow using swirl flowmeters
    • G01F1/3209—Measuring the volume flow or mass flow of fluid or fluent solid material wherein the fluid passes through a meter in a continuous flow by using mechanical effects by detection of dynamic effects of the flow using swirl flowmeters using Karman vortices
    • G01F1/3218—Measuring the volume flow or mass flow of fluid or fluent solid material wherein the fluid passes through a meter in a continuous flow by using mechanical effects by detection of dynamic effects of the flow using swirl flowmeters using Karman vortices bluff body design
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01F—MEASURING VOLUME, VOLUME FLOW, MASS FLOW OR LIQUID LEVEL; METERING BY VOLUME
    • G01F1/00—Measuring the volume flow or mass flow of fluid or fluent solid material wherein the fluid passes through a meter in a continuous flow
    • G01F1/05—Measuring the volume flow or mass flow of fluid or fluent solid material wherein the fluid passes through a meter in a continuous flow by using mechanical effects
    • G01F1/20—Measuring the volume flow or mass flow of fluid or fluent solid material wherein the fluid passes through a meter in a continuous flow by using mechanical effects by detection of dynamic effects of the flow
    • G01F1/32—Measuring the volume flow or mass flow of fluid or fluent solid material wherein the fluid passes through a meter in a continuous flow by using mechanical effects by detection of dynamic effects of the flow using swirl flowmeters
    • G01F1/325—Means for detecting quantities used as proxy variables for swirl
    • G01F1/3259—Means for detecting quantities used as proxy variables for swirl for detecting fluid pressure oscillations
    • G01F1/3266—Means for detecting quantities used as proxy variables for swirl for detecting fluid pressure oscillations by sensing mechanical vibrations
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01F—MEASURING VOLUME, VOLUME FLOW, MASS FLOW OR LIQUID LEVEL; METERING BY VOLUME
    • G01F1/00—Measuring the volume flow or mass flow of fluid or fluent solid material wherein the fluid passes through a meter in a continuous flow
    • G01F1/05—Measuring the volume flow or mass flow of fluid or fluent solid material wherein the fluid passes through a meter in a continuous flow by using mechanical effects
    • G01F1/20—Measuring the volume flow or mass flow of fluid or fluent solid material wherein the fluid passes through a meter in a continuous flow by using mechanical effects by detection of dynamic effects of the flow
    • G01F1/32—Measuring the volume flow or mass flow of fluid or fluent solid material wherein the fluid passes through a meter in a continuous flow by using mechanical effects by detection of dynamic effects of the flow using swirl flowmeters
    • G01F1/325—Means for detecting quantities used as proxy variables for swirl
    • G01F1/3273—Means for detecting quantities used as proxy variables for swirl for detecting fluid speed oscillations by thermal sensors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01F—MEASURING VOLUME, VOLUME FLOW, MASS FLOW OR LIQUID LEVEL; METERING BY VOLUME
    • G01F1/00—Measuring the volume flow or mass flow of fluid or fluent solid material wherein the fluid passes through a meter in a continuous flow
    • G01F1/76—Devices for measuring mass flow of a fluid or a fluent solid material
    • G01F1/86—Indirect mass flowmeters, e.g. measuring volume flow and density, temperature or pressure
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/475—Assays involving growth factors
    • G01N2333/515—Angiogenesic factors; Angiogenin

Landscapes

  • General Physics & Mathematics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Health & Medical Sciences (AREA)
  • Fluid Mechanics (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Analytical Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Endocrinology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pathology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medical Treatment And Welfare Office Work (AREA)
DK02801985T 2001-10-25 2002-10-24 Generering af en behandlingsprotokol for sygdomme relateret til angiogenese DK1485818T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US33059201P 2001-10-25 2001-10-25
US10/207,772 US7418374B2 (en) 2001-10-25 2002-07-31 Treatment protocol generation for diseases related to angiogenesis
PCT/IB2002/004725 WO2003036410A2 (fr) 2001-10-25 2002-10-24 Creation d'un protocole de traitement de maladies associees a l'angiogenese

Publications (1)

Publication Number Publication Date
DK1485818T3 true DK1485818T3 (da) 2007-06-18

Family

ID=26902569

Family Applications (1)

Application Number Title Priority Date Filing Date
DK02801985T DK1485818T3 (da) 2001-10-25 2002-10-24 Generering af en behandlingsprotokol for sygdomme relateret til angiogenese

Country Status (7)

Country Link
US (2) US7418374B2 (fr)
EP (1) EP1485818B1 (fr)
AT (1) ATE354132T1 (fr)
AU (1) AU2002363044A1 (fr)
DE (1) DE60218229T2 (fr)
DK (1) DK1485818T3 (fr)
WO (1) WO2003036410A2 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007094830A1 (fr) 2005-11-10 2007-08-23 In Silico Biosciences, Inc. Procédé et dispositif de modélisation informatique du cerveau humain devant permettre de prévoir les effets de médicaments

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999052025A2 (fr) * 1998-04-03 1999-10-14 Triangle Pharmaceuticals, Inc. SYSTEMES, PROCEDES ET PRODUITS DE PROGRAMMES INFORMATIQUES DESTINES A GUIDER LA SELECTION DE SCHEMAS THERAPEUTIQUES$i( )

Also Published As

Publication number Publication date
EP1485818A4 (fr) 2005-04-06
DE60218229D1 (de) 2007-03-29
EP1485818B1 (fr) 2007-02-14
WO2003036410A3 (fr) 2004-09-30
ATE354132T1 (de) 2007-03-15
AU2002363044A1 (en) 2003-05-06
US7418374B2 (en) 2008-08-26
DE60218229T2 (de) 2007-10-31
US20080275684A1 (en) 2008-11-06
WO2003036410A2 (fr) 2003-05-01
EP1485818A2 (fr) 2004-12-15
US20030088237A1 (en) 2003-05-08

Similar Documents

Publication Publication Date Title
Holcomb et al. Cross-modal semantic priming: A time-course analysis using event-related brain potentials
WO2001093745A3 (fr) Plan de traitement et visualisation assistes par ordinateur faisant appel au calage et a la fusion d'images
JP2003135683A5 (fr)
DE50206472D1 (de) Attenuierte lebendimpfstoffe
WO2002042480A3 (fr) Variant du virus de la vaccine modified vaccinia ankara
ATE506019T1 (de) Kontrollierbare vorrichtung und kit zur behandlung von störungen des herzrhythmus- reguliersystems
DE50211465D1 (de) Geburtensimulator
NO20044940L (no) Rekombinant poxvirus som uttrykker homologe gener innsatt i det poxvirale genomet
NO331251B1 (no) Faktor VII-polypeptidvariant, nukleinsyrekonstruksjon, rekombinant vertscelle, ikke-humant transgent dyr, fremgangsmate for fremstilling av faktor VII-poly¬peptidet, samt anvendelse av et faktor VII-polypeptid til fremstilling av et medi¬kament for behandling av blodningsepisoder
NO20031471L (no) Glykoformer av faktor VII
DK0998287T3 (da) Anvendelse af levobupivacain
BR0015561A (pt) Produto alimentìcio
DE50201780D1 (de) Halogensubstituierte aminodicarbonsäurederivate als arzneimittel zur behandlung von herz-kreislauf-erkrankungen
WO2003002106A3 (fr) Utilisation d'inhibiteurs de tyrosine kinase dans le traitement de maladies allergiques
DE60212627D1 (de) Die verwendung von n-phenyl-2-pyrimidine-amine derivaten zur behandlung von entzündlichen erkrankungen
DK1401416T5 (da) Anvendelse af C-kit-inhibitorer til behandling af inflammatorisk tarmsygdom
NO20031963D0 (no) Fremgangsmåter og preparater for behandling av sykdommer i öyet
DK1485818T3 (da) Generering af en behandlingsprotokol for sygdomme relateret til angiogenese
DE50211751D1 (de) Wasser-in-silikon-emulsionen
HUP0103712A2 (hu) Paroxetin sók, eljárás az előállításukra és gyógyászati alkalmazásuk
WO2002009590A1 (fr) Dispositif supportant un tissu pour traitement medical
JP2006521133A5 (fr)
Chisari et al. Modulation of cerebral vascular tone by activated glia: involvement of nitric oxide
Lawler et al. Predictability of foot shock differentially affects the phasic blood pressure of SHR, BHR, and WKY rats
WO2002044403A3 (fr) Marqueurs destines au test d'analogues de la vitamine d et applications therapeutiques associees